|
?:abstract
|
-
Objective The epidemiology of psychiatric symptoms among COVID-19 patients is poorly characterized This paper seeks to identify the prevalence of anxiety, depression, and acute stress disorder among hospitalized patients with COVID-19 Methods Adult patients recently admitted to non-ICU medical ward settings with COVID-19 were eligible for enrollment Enrolled patients were screened for depression, anxiety, and delirium Subsequently, patients were followed by phone after two weeks and re-screened for depression, anxiety, and acute stress disorder symptoms Subjects’ medical records were abstracted for clinical data Results 58 subjects were enrolled of whom 44 completed the study Initially, 36% of subjects had elevated anxiety symptoms and 29% elevated depression symptoms At two-week follow-up, 9% had elevated anxiety symptoms, 20% elevated depression symptoms, and 25% mild-to-moderate acute stress disorder symptoms Discharge to home was not associated with improvement in psychiatric symptoms Conclusion A significant number of patients hospitalized with COVID-19 experience symptoms of depression and anxiety While anxiety improves following index admission, depression remains fairly stable Furthermore, a significant minority of patients experience acute stress disorder symptoms, though these are largely mild-to-moderate
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}